Cafepharma Today

September 22 2023 - Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Merck, Seagen, and Astellas get late-stage win in bladder cancer
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses
Novo Nordisk Foundation to establish €127 million cell therapy plant
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Fast Company
Friday, September 22, 2023 - 12:03pm
tags:
Novo Nordisk, Ozempic, logo, branding, diabetes, weight loss
Could Gilead’s Trodelvy be the next TROP-2 therapy game-changer in NSCLC treatment?
Clinical Trials Arena
Friday, September 22, 2023 - 12:00pm
tags:
Gilead Sciences, Trodelvy, TROP-2, non-small cell lung cancer
Covid Drug Paxlovid Now Less Effective Than In Early Trials—But It’s Still Great At Preventing Death
Forbes
Friday, September 22, 2023 - 11:58am
tags:
Pfizer, Paxlovid, clinical trials, COVID-19
Boston Scientific expects ‘dramatic shift’ to pulsed field ablation to fuel fast growth through 2026
Medtech Dive
Friday, September 22, 2023 - 11:56am
tags:
Medtech, Boston Scientific, pulsed field ablation
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
BioSpace
Friday, September 22, 2023 - 11:53am
tags:
Merck, Seagen, Astellas, urothelial cancer, clinical trials, bladder cancer, Padcev, Keytruda
AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead
BioSpace
Friday, September 22, 2023 - 11:51am
tags:
AstraZeneca, Daiichi Sankyo, breast cancer, antibody-drug conjugate, clinical trials
FDA greenlights Jardiance for treating chronic kidney disease
Medical Marketing and Media
Friday, September 22, 2023 - 11:50am
tags:
Eli Lilly, Boehringer Ingelheim, Medicare, Jardiance, FDA, chronic kidney disease
FDA panel votes against diabetes implant due to safety concerns
Reuters
Friday, September 22, 2023 - 11:48am
tags:
Intarcia, diabetes, FDA, ITCA 650, Medtech
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Friday, September 22, 2023 - 11:46am
tags:
Merck, Eisai, Keytruda, Lenvima, melanoma, colorectal cancer, non-small cell lung cancer
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO
Fierce Biotech
Friday, September 22, 2023 - 11:42am
tags:
AbPro, IPOs, SPAC, NASDAQ
FDA approves Krystal Biotech’s KB408 for AATD treatment
Pharmaceutical Business Review
Friday, September 22, 2023 - 10:10am
tags:
Krystal Biotech, KB408, alpha-1 antitrypsin deficiency
Novo Nordisk Foundation to establish €127 million cell therapy plant
Biopharma Reporter
Thursday, September 21, 2023 - 6:39pm
tags:
Novo Nordisk, cell therapy, Denmark
HIV Vaccine Trial of Vir Biotech’s New Candidate VIR-1388 Begins
Xtalks
Thursday, September 21, 2023 - 6:36pm
tags:
Vir Biotechnology, clinical trials, HIV, VIR-1388
Amgen unveils Partners of Choice oncology network
Medical Marketing and Media
Thursday, September 21, 2023 - 6:35pm
tags:
Amgen, expert panels, oncology, cancer
Travere’s Kidney Disease Drug Narrowly Misses Phase III Endpoint, Stock Tanks
BioSpace
Thursday, September 21, 2023 - 6:34pm
tags:
Travere Therapeutics, kidney disease, sparsentan, Filspari, clinical trials
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Yahoo/Zacks.com
Thursday, September 21, 2023 - 6:32pm
tags:
Merck, Keytruda, FDA, cervical cancer, priority review
AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims
Reuters
Thursday, September 21, 2023 - 11:57am
tags:
AstraZeneca, legal, remote work, employment law
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
Benzinga
Thursday, September 21, 2023 - 11:55am
tags:
Inmagene, Aditum Bio, Celexor, autoimmune disease, inflammatory disease
Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar
BioSpace
Thursday, September 21, 2023 - 11:53am
tags:
Alvotech, FDA, biosimilars, AVT02, AbbVie, Humira
Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off
Fierce Pharma
Thursday, September 21, 2023 - 11:51am
tags:
Takeda, generics, gout, Colcrys, antitrust

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award
PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Klick Health launches new healthcare venture studio
Medtech earnings reports: insights from major players' Q4 results
Key compliance issues for medtech firms transitioning to data-enabled solutions
Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

A Clear Path to Education Affordability Requires Meeting Patients Where They Are
Drug Channels
NEW: The Drug Channels 2024 Video Webinar Series
Drug Channels
Do Plan Sponsors Understand How Their PBMs Make Money?
Drug Channels
Informa Connect’s Patient Support Services Congress
Drug Channels
How Payers Are Reacting to Insulin Price Changes
Drug Channels
White Bagging Update 2023: Saving Money or Shifting Costs?
Drug Channels
Available for Preorder: The 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
Drug Channels
What Pharmaceutical Manufacturers Value Most from a Hub
Drug Channels
What’s Behind CVS Health’s Novel Vertical Integration Strategy for Humira Biosimilars
Drug Channels

Latest Jobs

Workplace Planning Associate - Merrimack, NH
Boston, Massachusetts
Fidelity Investments
2020-2023 Undergraduates, Customer Relationship Advocate - Salt Lake City, UT
Heber City, Utah
Fidelity Investments
Field Clinical Manager, Structural Heart
Philadelphia, PA, 19117
Medtronic
Workplace Planning Associate - Smithfield, RI
Smithfield, Rhode Island
Fidelity Investments
Call Center Representative
Bountiful, Utah
Fidelity Investments
Workplace Planning Associate - Smithfield, RI
Springfield, Massachusetts
Fidelity Investments
Customer Experience Rep
Bountiful, Utah
Fidelity Investments
Call Center Representative
Park City, Utah
Fidelity Investments
Customer Service Representative
Bountiful, Utah
Fidelity Investments
Hospice Care Consultant
Clarksville, TN, 37040
Gentiva Hospice
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information